Collimation Medical Technologies Private Limited
Collimation Medical Technologies Private Limited is a Private Non-govt company company incorporated in 2015 and based in Haryana, India. It was founded by Sandeep. Collimation Medical Technologies Private Limited operates in Medical & Precision (NIC 33110) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2023-24, the company reported revenue of ₹2.74 Cr and profit after tax of ₹3.41 L. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +36d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +14d | filed |
| MGT-7 | FY2022-23 | 22 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Collimation Medical Technologies Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 761562471 | State Bank of India(Bank) | ₹21.00 Cr | 19 Sep 2022 | Open |
| 396121250 | Kotak Mahindra Bank Ltd(Bank) | ₹13.91 Cr | 12 Mar 2023 | Open |
| 277090145 | State Bank of India(Bank) | ₹23.85 Cr | 19 Sep 2020 | Open |
| 975221403 | Kotak Mahindra Bank Ltd(Bank) | ₹15.84 Cr | 12 Mar 2020 | Open |
Charge IDs, lenders & amounts for Collimation Medical Technologies Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +19.0% | +7.0% | +89.0% | |
| Profit after Tax2023-24 | +66.0% | +81.0% | +73.0% | |
| Net Worth2023-24 | +55.0% | +26.0% | +80.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +0.05% | — | +0.85% | +0.01% | 76.11 | |||
| 2016-17 | +0.74% | +697.91% | +49.25% | +2.25% | 21.85 | |||
| 2017-18 | +1.04% | +18.06% | +44.87% | +3.27% | 13.73 | |||
| 2018-19 | +0.81% | +42.87% | +33.24% | +2.63% | 12.64 | |||
| 2020-21 | +0.82% | +11.38% | +21.52% | +2.69% | 8.00 | |||
| 2021-22 | +1.05% | -15.76% | +18.82% | +2.04% | 9.21 | |||
| 2022-23 | +1.23% | -26.94% | +13.85% | +1.47% | 9.46 | |||
| 2023-24 | +1.25% | +79.85% | +20.12% | +2.37% | 8.49 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 54,55,455 | 84.44% |
| Institutional Investors | 2 | 2,55,592 | 3.96% |
| Public & Others | 57 | 7,49,603 | 11.60% |
Promoter, institutional & public holding for Collimation Medical Technologies Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
21 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.